CUMBERLAND PHARMACEUTICALS INC (CPIX) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Dilution Analysis

Medium Risk

Moderate dilution risk

Last updated: May 08, 2026

Risk Assessment Details

Potential Dilution: 389.79% of current shares

Recent Dilution: 6.45% (2 years)

Historical Dilution Factor: minimal recent dilution

Outstanding Shares

15M

Potential Supply

58M

Additional shares possible

Splits

None

Past 2 years

Summary

CPIX currently has 15M outstanding shares. with significant dilution risk as 58.3M authorized shares could dilute existing holders by 389.8%. The company has minimally diluted shareholders by 6.45% over the past 2 years.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding	Supply
May 08, 2026	10-Q filing \| 15.0M shares outstanding	15M	58M
Nov 07, 2025	10-Q filing \| 15.0M shares outstanding	15M	58M
May 09, 2025	10-Q filing \| 14.9M shares outstanding	15M	58M
Mar 07, 2025	10-K filing \| 14.1M shares outstanding	14M	59M
Nov 08, 2024	10-Q filing \| 14.1M shares outstanding	14M	59M
Aug 09, 2024	10-Q filing \| 14.1M shares outstanding	14M	59M
May 10, 2024	10-Q filing \| 14.1M shares outstanding	14M	59M
Mar 13, 2024	10-K filing \| 14.3M shares outstanding	14M	59M
Dec 14, 2023	S-3 filing: The company may offer and sell, from time to time in one or more offerings, up to $100,000,000 in the aggregate of common stock, preferred stock, or warrants to purchase our common stock or preferred stock, debt securities and/or units consisting of two or more of those classes or series of securities and securities that may be convertible or exchangeable to other securities covered hereby, at prices and on terms that we will determine at the time of the offering.	14M	59M
Nov 13, 2023	10-Q filing \| 14.3M shares outstanding	14M	860K
Aug 11, 2023	10-Q filing \| 14.4M shares outstanding	14M	740K
May 12, 2023	10-Q filing \| 14.4M shares outstanding	14M	780K
Mar 13, 2023	10-K filing \| 14.6M shares outstanding	15M	570K
Nov 14, 2022	10-Q filing \| 14.5M shares outstanding	14M	660K
Aug 12, 2022	10-Q filing \| 14.7M shares outstanding	15M	450K
May 13, 2022	10-Q filing \| 14.7M shares outstanding	15M	440K
Mar 11, 2022	10-K filing \| 14.9M shares outstanding	15M	230K
Dec 27, 2021	8-K filing: Cumberland Pharmaceuticals Inc. filed a prospectus supplement in connection with its "at-the-market" offering program for the offer and sale of up to $19,000,000 of shares of the Company's common stock through B. Riley Securities, Inc. Prior to the date hereof, an aggregate of 30,704 Shares were sold under the Sales Agreement for aggregate gross proceeds of approximately $200,909. ($0.2M proceeds)	15M	250K
Nov 12, 2021	10-Q filing \| 14.9M shares outstanding	15M	250K
Aug 13, 2021	10-Q filing \| 15.0M shares outstanding	15M	160K
May 14, 2021	10-Q filing \| 15.0M shares outstanding	15M	160K
Mar 12, 2021	10-K filing \| 15.2M shares outstanding	15M	0
Dec 11, 2020	S-3 filing: Cumberland Pharmaceuticals Inc. is filing an S-3 to register an aggregate offering of up to $100,000,000 in common stock, preferred stock, warrants, debt securities, and/or units.	15M	0
Nov 13, 2020	10-Q filing \| 15.1M shares outstanding	15M	0
Aug 14, 2020	10-Q filing \| 15.2M shares outstanding	15M	0
May 22, 2020	10-Q filing \| 15.2M shares outstanding	15M	0
Mar 20, 2020	10-K filing \| 15.4M shares outstanding	15M	0

Back to CPIX Details